4//SEC Filing
Ziessler Steven D 4
Accession 0001181431-10-005140
CIK 0001295976other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 3:37 PM ET
Size
23.4 KB
Accession
0001181431-10-005140
Insider Transaction Report
Form 4
Ziessler Steven D
DirectorPres. Tissue & Mach-Gl, COO
Transactions
- Conversion
Common Stock
2010-01-27+18,327→ 155,753 total - Sale
Common Stock
2010-01-27$13.00/sh−123,841$1,609,933→ 257,552 total - Conversion
Series A Preferred Stock
2010-01-27−137,426→ 0 total→ Common Stock (137,426 underlying) - Conversion
Common Stock
2010-01-27+225,640→ 381,393 total - Conversion
Series B Preferred Stock
2010-01-27−18,327→ 0 total→ Common Stock (18,327 underlying) - Award
Employee Stock Option
2010-01-27+45,878→ 45,878 totalExercise: $11.45Exp: 2020-01-27→ Common Stock (45,878 underlying) - Conversion
Common Stock
2010-01-27+137,426→ 137,426 total - Conversion
Common Stock
2010-01-27−225,640→ 0 total→ Common Stock (225,640 underlying) - Other
Employee Stock Option
2010-01-27+138,662→ 138,662 totalExercise: $5.28Exp: 2019-04-13→ Common Stock (138,662 underlying) - Other
Employee Stock Option
2010-01-27−138,662→ 0 totalExercise: $5.28Exp: 2019-04-13→ Common Stock (138,662 underlying)
Footnotes (6)
- [F1]Series A Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
- [F2]Series B Preferred Stock of Cellu Parent Corporation was converted into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation was merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
- [F3]Reporting person was granted shares of Restricted Stock in Cellu Parent Corporation on June 12, 2006, of which 75% had vested. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering and upon the closing of the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation Common Stock was exchanged for fully vested shares of Issuer Common Stock.
- [F4]Reporting person held an option to purchase shares of Common Stock in Cellu Parent Corporation. Pursuant to the terms of the reorganization transactions that were consummated in connection with the Issuer's initial public offering, as described in the Issuer's Form S-1 Registration Statement dated January 21, 2010, the Cellu Parent Corporation options were exchanged for options to purchase Issuer Common Stock.
- [F5]Upon the closing of the Issuer's initial public offering and on the date of the exchange, options to purchase 45,024 shares became fully vested and options for the remaining shares will vest as to 33.33% of the shares each year beginning on the first anniversary date of the closing of the Issuer's initial public offering.
- [F6]Stock option grant under the Issuer's 2010 Equity Compensation Plan. Vests in four equal installments annually beginning on January 27, 2011.
Documents
Issuer
Cellu Tissue Holdings, Inc.
CIK 0001295976
Entity typeother
Related Parties
1- filerCIK 0001480567
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 3:37 PM ET
- Size
- 23.4 KB